Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females

• Główni autorzy: Li-Wei Shi (Autor), Juan Li (Autor), Bang-Wei Yu (Autor), Li-Rong Huang (Autor), Ke Li (Autor), Min Ji (Autor), Ling-Yun Zhou (Autor), Lin Yuan (Autor), Shu-Yuan Yang (Autor), Jing-Jing Chen (Autor), Ling Wang (Autor), Zhi-Wei Jiang (Autor), Rong-Cheng Li (Autor), Yan-Ping Li (Autor), Jie-Lai Xia (Autor), Zhao-Jun Mo (Autor), Chang-Gui Li (Autor)
• Format: Książka
• Wydane: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

As global supply is still inadequate to address the worldwide requirements for HPV vaccines, we assessed the safety and immunogenicity of a new bivalent HPV16/18 vaccine. In this randomized, double-blind, placebo-controlled, phase 2 trial, healthy 9-45-year-old Chinese females in three age cohorts (...